JP2022554230A5 - - Google Patents
Info
- Publication number
- JP2022554230A5 JP2022554230A5 JP2022524568A JP2022524568A JP2022554230A5 JP 2022554230 A5 JP2022554230 A5 JP 2022554230A5 JP 2022524568 A JP2022524568 A JP 2022524568A JP 2022524568 A JP2022524568 A JP 2022524568A JP 2022554230 A5 JP2022554230 A5 JP 2022554230A5
- Authority
- JP
- Japan
- Prior art keywords
- methylumbelliferone
- derivatives
- salts
- use according
- allyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926001P | 2019-10-25 | 2019-10-25 | |
| US62/926,001 | 2019-10-25 | ||
| PCT/EP2020/079979 WO2021078991A1 (en) | 2019-10-25 | 2020-10-25 | Treatment of conditions of the nervous system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022554230A JP2022554230A (ja) | 2022-12-28 |
| JP2022554230A5 true JP2022554230A5 (cg-RX-API-DMAC7.html) | 2023-11-06 |
| JP7883950B2 JP7883950B2 (ja) | 2026-07-02 |
Family
ID=73455660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022524568A Active JP7883950B2 (ja) | 2019-10-25 | 2020-10-25 | 神経系の状態の処置 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220380331A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4048257A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7883950B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115023222A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021078991A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4440571A1 (en) * | 2021-11-30 | 2024-10-09 | Evexys Biotech OY | Prevention and treatment of depressive disorders and conditions promoted by protease containing plasma extracellular vesicles (pcpev) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9810016D0 (en) * | 1998-05-08 | 1998-07-08 | Smithkline Beecham Plc | Compounds |
| BRPI0609265A2 (pt) * | 2005-03-29 | 2010-03-09 | Newron Pharm Spa | derivados de aminoalquil-e amidoalquil-benzopiran substituìdos |
| CN103446154A (zh) * | 2012-05-29 | 2013-12-18 | 中国医学科学院药物研究所 | 香豆素衍生物在防治脑部重大疾病中的应用 |
| US10285976B2 (en) * | 2013-08-12 | 2019-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | 4-methylumbelliferone treatment for immune modulation |
| US10370400B2 (en) * | 2017-01-13 | 2019-08-06 | The Board Of Trustees Of The Leland Stanford Junior University | 4-methylumbelliferone derivatives for treatment for immune modulation |
| US11278518B2 (en) * | 2017-01-13 | 2022-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treatment using 4-methylumbelliferone and derivatives thereof |
-
2020
- 2020-10-25 CN CN202080093141.6A patent/CN115023222A/zh active Pending
- 2020-10-25 EP EP20808020.0A patent/EP4048257A1/en active Pending
- 2020-10-25 JP JP2022524568A patent/JP7883950B2/ja active Active
- 2020-10-25 WO PCT/EP2020/079979 patent/WO2021078991A1/en not_active Ceased
- 2020-10-25 US US17/771,758 patent/US20220380331A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111989332A (zh) | 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用 | |
| KR101605151B1 (ko) | 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드 | |
| AU2008322595B2 (en) | Method of treating arthritis | |
| JP2009521494A5 (cg-RX-API-DMAC7.html) | ||
| JP2010500376A5 (cg-RX-API-DMAC7.html) | ||
| JP2018515495A5 (cg-RX-API-DMAC7.html) | ||
| US10493097B2 (en) | Silicate containing compositions and methods of treatment | |
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| RU2002111355A (ru) | Производные 5бета-сапогенина и псевдосапогенина и их применение при лечении деменции | |
| JP7471685B2 (ja) | 新規な化合物およびそれを含むがんの予防または治療用薬学組成物 | |
| BRPI0823522A2 (pt) | Uso de um composto derivado de ceramida | |
| JP2019505529A5 (cg-RX-API-DMAC7.html) | ||
| JP2012510985A5 (cg-RX-API-DMAC7.html) | ||
| JP2015522592A5 (cg-RX-API-DMAC7.html) | ||
| CN105209037A (zh) | 用于治疗癌症、神经障碍和纤维化病症的脂类呋喃、吡咯和噻吩化合物 | |
| WO2016203468A1 (en) | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof | |
| JP5017268B2 (ja) | 覚醒を改善する方法 | |
| CN114344313A (zh) | 用于预防或治疗神经系统退行性疾病的白桦脂酸衍生物 | |
| EP3288932A1 (en) | Novel epha4 inhibitors targeting its ligand binding domain | |
| RU2732417C1 (ru) | Производные фенотиазина и способы их применения | |
| WO2019028270A1 (en) | MATERIALS AND METHODS FOR DELETING AND / OR TREATING BONE-RELATED DISEASES AND SYMPTOMS | |
| RU2006104241A (ru) | Пароксетин холат или соли производных холевой кислоты и композиция содержащая пароксетин и холевую кислоту или производные холевой кислоты | |
| EP4048663A1 (en) | Quinolone carboxylic derivatives | |
| CN1879619A (zh) | 癌症治疗 | |
| RU2470939C2 (ru) | Полипептидное соединение |